Aurinia Pharmaceuticals Inc.·4

Feb 23, 4:08 PM ET

Donley Matthew Maxwell 4

4 · Aurinia Pharmaceuticals Inc. · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Aurinia (AUPH) COO Matthew Donley Withholds 32,901 Shares for Taxes

What Happened

Matthew Donley, Chief Operating Officer of Aurinia Pharmaceuticals (AUPH), had 32,901 shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. The withholding was recorded as a disposition at $14.40 per share, totaling approximately $473,774. This was a tax-withholding transaction (not an open-market sale or a purchase).

Key Details

  • Transaction date: February 20, 2026
  • Price: $14.40 per share; shares withheld: 32,901; total value ~ $473,774
  • Filing date / Period of report: Form 4 filed Feb 23, 2026 reporting the Feb 20, 2026 event
  • Transaction code: F (shares withheld to satisfy tax withholding on RSU vesting) — see footnote F1
  • Shares owned after transaction: Not disclosed in the provided filing
  • No 10b5-1 plan, late-filing indicator, or other special codes are noted in the supplied data

Context

This was a cashless tax-withholding action tied to RSU vesting: instead of paying taxes in cash, the company withheld and retained shares to cover the tax bill. Such withholding is routine and typically reflects tax mechanics rather than a deliberate sale by the insider to realize gains or signal sentiment.

Insider Transaction Report

Form 4
Period: 2026-02-20
Donley Matthew Maxwell
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-02-20$14.40/sh32,901$473,774662,900 total
Footnotes (1)
  • [F1]Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units.
Signature
/s/ Matthew Maxwell Donley|2026-02-23

Documents

1 file
  • 4
    wk-form4_1771880882.xmlPrimary

    FORM 4